Method development and validation for the analysis of meloxicam in tablets by CZE
Authors:
- 11 January 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 31 (2) , 393-400
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Spectrophotometric and fluorimetric methods for the determination of meloxicam in dosage formsJournal of Pharmaceutical and Biomedical Analysis, 2002
- ELECTROCHEMICAL OXIDATION OF MELOXICAM AND ITS DETERMINATION IN TABLET DOSAGE FORMAnalytical Letters, 2001
- Spectrophotometric methods for determining meloxicam in pharmaceuticals using batch and flow-injection proceduresEuropean Journal of Pharmaceutical Sciences, 2000
- Clinical Pharmacokinetics of MeloxicamClinical Pharmacokinetics, 1999
- Determination of Meloxicam in Tablet Formulations by Ultraviolet Spectrophotometry and High-Performance Liquid ChromatographyAnalytical Letters, 1999
- Stability-Indicating Method for the Determination of Meloxicam and Tetracaine Hydrochloride in the Presence of their Degradation ProductsSpectroscopy Letters, 1998
- A Review of the Clinical Pharmacokinetics of MeloxicamRheumatology, 1996
- MeloxicamDrugs, 1996
- Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal toleranceInflammation Research, 1995
- Validated capillary electrophoresis method for the assay of a range of basic drugsJournal of Pharmaceutical and Biomedical Analysis, 1995